John P. Veluchamy

512 citations
9 papers · 399 indexed · h-index 7
Topics
Immune Cell Function and Interaction (8 papers)CAR-T cell therapy research (6 papers)Hematopoietic Stem Cell Transplantation (4 papers)
Partner nations
NetherlandsGermanyFrance

In The Last Decade

John P. Veluchamy

8 papers receiving 390 citations

Peers

John P. Veluchamy
Comparison fields: 5 of 40
  • Immunology 309
  • Oncology 281
  • Hematology 60
  • Molecular Biology 59
  • Radiology, Nuclear Medicine and Imaging 44
Replace Dave Ankarlo with:
Dave Ankarlo United States
Ariane Thielens France
Lois Hageman Netherlands
Tineke Aarts‐Riemens Netherlands
F Triebel France
Behiye Kodal United States
P. S. A. Becker Germany
Meighan M. Gallagher United States
Hilde Omholt Norway
Ashley Ambrose United Kingdom
John P. Veluchamy relative to Dave Ankarlo United States Dave Ankarlo's profile →
Citations per field
00.5×1.7×
Dave Ankarlo · 1×
Citations per year

Countries citing papers authored by John P. Veluchamy

Since Specialization
Citations

This map shows the geographic impact of John P. Veluchamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Veluchamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Veluchamy more than expected).

Fields of papers citing papers by John P. Veluchamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Veluchamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Veluchamy. The network helps show where John P. Veluchamy may publish in the future.

Co-authorship network of co-authors of John P. Veluchamy

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Veluchamy. A scholar is included among the top collaborators of John P. Veluchamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Veluchamy. John P. Veluchamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 4
2 38
3 148
4 21
5 68
6 29
7 25
8 66
9 0

About John P. Veluchamy

John P. Veluchamy is a scholar working on Immunology, Hematology and Oncology, having authored 9 papers that have together received 399 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (6 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Immunology (309 citations), Oncology (281 citations) and Hematology (60 citations). John P. Veluchamy has collaborated with scholars based in Netherlands, Germany and France. Frequent co-authors include Tanja D. de Gruijl, Hans van Vliet, Henk M.W. Verheul, Jan Spanholtz, Nina Kok, Daniëlle A.M. Heideman, Victor L. Thijssen, Marleen Tordoir, Silvia Lopez‐Lastra and James P. Di Santo. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026